Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity
Feng Yang,1 Aimei Li,2 Han Liu,3 Hairong Zhang1 1Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining 272029, Shandong, People’s Republic of China; 2Department of Anesthesiology, Affiliated Hospital of Jining Medical University, Jining 272029, Shandong,...
Saved in:
Main Authors: | Yang F (Author), Li A (Author), Liu H (Author), Zhang H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy
by: Du M, et al.
Published: (2022) -
Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib
by: Ki-Young Huh, et al.
Published: (2021) -
Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers
by: You P, et al.
Published: (2017) -
Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles
by: Liu J, et al.
Published: (2018) -
The Development of Lipid-Based Sorafenib Granules to Enhance the Oral Absorption of Sorafenib
by: Jaylen C. Mans, et al.
Published: (2023)